Association of diabetes status and glycemic control with secondary prevention medication adherence after acute myocardial infarction
Kylie Adamek, Deepa Ramadurai, Elise Gunzburger, Mary E. Plomondon, P. Michael Ho, Sridharan Raghavan Table S1 . Baseline characteristics of individuals with diabetes, stratified by baseline hemoglobin A1c. Table S2 . Distribution of diabetes patients in the study based on time between HbA1c measurement and hospitalization for acute myocardial infarction. Table S3 . Unadjusted medication adherence across HbA1c categories among individuals with diabetes. Table S4 . Association between HbA1c category and likelihood of achieving 1-year proportion of days covered of at least 0.8 after acute myocardial infarction. Table S5 . Association between HbA1c category and likelihood of achieving 1-year proportion of days covered of at least 0.8 after acute myocardial infarction among individuals with HbA1c measurement within 90 days of cardiac catheterization. Table S6 . Association between HbA1c category and likelihood of achieving 1-year proportion of days covered of at least 0.8 after acute myocardial infarction among individuals with HbA1c measurement within 180 days of cardiac catheterization. Table S7 . Achievement of secondary prevention medication adherence for those without versus with poorly-controlled diabetes. Figure S1 . Flow chart of study cohort development from VA electronic health records. (2) 2184 (98) 42 (2) 1724 (98) 29 (2) 1102 (98) 26 (2) 1474 (97) 141 (22) 489 (22) 375 (21) 258 (23) 273 (18) 0.01 CKD, n (%)
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Abbreviations: PDC, proportion of days covered; Statin, HMG-CoA reductase inhibitor; ACEi, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker. * Adjusted for age, race, sex, comorbidities (congestive heart failure, peripheral artery disease, chronic obstructive pulmonary disease, post-traumatic stress disorder, chronic kidney disease, dialysis use, and depression) 
